Eileen O'Reilly
Chair, Human Research Protection Program and Institutional Review Board · New York Presbyterian Hospital
Credentials: · ·
History
PresentHuman Research Protection Program and Institutional Review Board Department · New York Presbyterian Hospital
- Present
Medical · New York Presbyterian Hospital
- Present
HPB & Neuroendocrine Cancers Section · New York Presbyterian Hospital
- 1997–1998
- 1993–1995
Internal Medicine/Medical Oncology
- 1990–1993
Research
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
New England Journal of Medicine · 2019 · 1,858 citations
Review · JAMA · 2021 · Last of 3 authors · 1,602 citations
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
Nature · 2023 · 1,126 citations
- GA
100 papers
- DK
67 papers
67 papers
- WJ
66 papers
- ML
58 papers · 34 as a resident
- WP
58 papers
51 papers
- AW
48 papers
Grants
- 2022–2027
The Memorial Sloan Kettering Cancer Center SPORE in Pancreas Cancer
National Cancer Institute · P50
Contact PI · $11.9M · Sloan-Kettering Inst Can Research
Clinical trials
- 2022–2026
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)
Principal investigator · Active not recruiting · Phase 1, Phase 2
Memorial Sloan Kettering Cancer Center
- 2020–2026
Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer
Principal investigator · Active not recruiting · Phase 1, Phase 2
Memorial Sloan Kettering Cancer Center
- 2018–2023
Principal investigator · Unknown · Phase 2
Silenseed Ltd
- 2015–2017
Principal investigator · Completed · Phase 2
AstraZeneca